Consistent with the result of previous publications, we also found neutrophil count, PLT count, and Hb levels were independent prognostic factors for OS in metastatic NSCLC patients treated with concurrent chemoradiotherapy. This evidence concerns the gene GSTM1 and non-small cell lung carcinoma.